Funding · Company
Abrexa Pharmaceuticals, Inc.
San Diego, CAHealthcare
Abrexa Pharmaceuticals, Inc. of San Diego, CA has disclosed $23M across 1 Form D offering filed with the SEC on Apr 28, 2025.
$23M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersSan Diego, CAIndustryHealthcare (Other Health Care)SEC CIK0001529349Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →